Company Snapshot: COHR  Print This Story  Email This Story  Save this Link View PR Newswire's RSS Feed  Blogs Discussing this News Release  Search Blogs that Mention this News Release  Click this link to view linked Bookmarking Services Click this link to view linked Blogging Services


Coherent, Inc. Reports Second Quarter Results

    SANTA CLARA, Calif., April 26 /PRNewswire-FirstCall/ -- Coherent, Inc.
(Nasdaq: COHR) today announced financial results for its second fiscal quarter
ended April 2, 2005, with sales of $131.2 million and income from continuing
operations of $19.6 million ($0.63 per diluted share).  These results include
a tax benefit from the reversal of a deferred tax valuation allowance of $9.6
million ($0.31 per diluted share) relating to our Lambda Physik segment, and a
favorable adjustment of $0.3 million or $0.01 per diluted share, related to
our Lambda Physik segment's previously communicated decision to discontinue
future lithography investments.
    Sales and net income for the corresponding prior year quarter were $125.8
million and $3.0 million ($0.10 per diluted share), respectively.   In
comparison, the immediately preceding quarter's results were $126.0 million in
sales and a net income of $5.4 million ($0.17 per diluted share).  The first
quarter 2005 results included a charge of $3.1 million ($0.10 per diluted
share) related to the discontinuance of future product development and
investments in the semiconductor lithography market within our Lambda Physik
segment and a tax benefit of $0.5 million ($0.02 per diluted share) related to
federal tax law changes.
    Orders received during the quarter ended April 2, 2005 were $129.4
million, compared to a record high of $137.4 million in the same period last
year, and $128.6 million in the immediately preceding quarter.  Backlog of
$155.3 million at April 2, 2005 compared to a backlog of $157.1 million at
January 1, 2005.
    John Ambroseo, Coherent's President and Chief Executive Officer,
commented, "I'm pleased to report that Coherent has again delivered solid
financial results.  In addition to expanding gross and operating profits, we
have posted another quarter of good cash generation from continuing
operations, thereby satisfying one of our key business metrics. Our
performance in the second quarter benefited from our market diversification as
well as our continued emphasis on operational efficiency."
    Year-to-date sales of $257.2 million and net income of $25.0 million
($0.81 per diluted share) compared to the prior year period sales of $233.8
million and a net income of $3.2 million ($0.11 per diluted share).  Orders
received for the six month period ended April 2, 2005 were $257.9 million,
compared to $264.2 million in orders received during the same period a year
ago.
    Electro-Optics segment sales of $105.4 million for the three months ended
April 2, 2005 were 1% higher than sales during the comparable prior year
period and 4% higher than the three months ended January 1, 2005.  Incoming
orders of $100.0 million decreased 8% from the second fiscal quarter of 2004,
and represent an increase of 3% from orders received in the immediately
preceding quarter.  Sales and incoming orders for the six months ended April
2, 2005 were $206.3 million and $197.1 million, 6% higher and 9% lower,
respectively, than during the same period a year ago.
    Lambda Physik segment sales of $25.8 million for the three months ended
April 2, 2005 represent an increase of 18% from the corresponding prior year
period, and a 3% gain from the immediately preceding quarter.  Incoming orders
of $29.3 million for the second quarter of fiscal 2005 were 4% higher than the
second fiscal quarter of 2004, and represent a 7% decline from orders received
in the immediately preceding first fiscal quarter of 2005.  Sales and incoming
orders for the six months ended April 2, 2005 were $50.9 million and $60.9
million, 30% and 26% higher, respectively, than the same period last year.
    Ambroseo continued, "With respect to future demand, there are some
positive signs for products used in flat panel display manufacturing,
electronics packaging and materials processing.  It is also noteworthy that
our Lambda segment turned the corner of profitability for the first time in
more than two years.  This is a gratifying development and is another step in
Lambda's march towards operational and financial excellence."

    Coherent to Restate Financials for Fiscal Years 2000 through 2004 and the
First Quarter of Fiscal 2005; Amounts Not Material in Any Fiscal Year and
Unrelated to Core Operations
    Coherent also announced today that it will restate its financial
statements for fiscal years 2000 through 2004 and the first quarter of fiscal
2005 to correct its accounting for its deferred compensation plans.  The
corrections are not material to the reported net income or loss for the
applicable fiscal years or the first quarter of fiscal 2005 and do not relate
to the core operations of the Company.  The Company identified the accounting
error during the current quarter when the administration of the plans was
changed to a new third-party administrator.  In 1999, the Company amended its
non-qualified deferred compensation plan (Plan) and introduced a new
investment structure whereby the then existing and future contributions to the
Plan were funded in Company-owned life insurance contracts.  Since the change
in investment structure to Company-owned life insurance contracts, the Company
has accounted for the Plan by recording the participants' balances as a
liability equal to the obligation to the participants and the related asset
investments in the equivalent amount.  As a result of the Company's review, it
was determined that the asset investments should have been recorded at the
cash surrender value of the insurance contracts; life insurance premiums
loads, policy fees, and cost of insurance that were paid from the asset
investments and gains and losses from the asset investments should have been
recorded by the Company as components of other income or expenses; and
increases in the obligation to the participants should have been recorded as
operating expenses.  The Company has implemented enhanced procedures to
identify any potential issues that may arise associated with the accounting
for its deferred compensation plans.


    The impact of the restatement for each of affected periods can be
summarized as follows (unaudited, in thousands except per share data):

                                         Quarter Ended
                                            Jan. 1,   Fiscal Year  Fiscal Year
                                              2005        2004         2003
    Net income (loss) as reported            $5,391     $17,719     $(45,891)
    Impact of accounting correction              (3)       (359)        (255)
    Net income (loss) as restated            $5,388     $17,360     $(46,146)

    Earnings per share (previously
     reported):
      Basic                                   $0.18       $0.59       $(1.56)
      Diluted                                 $0.17       $0.58       $(1.56)

    Accounting correction:
      Basic                                    $--        $(0.01)      $(0.01)
      Diluted                                  $--        $(0.01)      $(0.01)

    Earnings per share (as restated):
      Basic                                   $0.18       $0.58       $(1.57)
      Diluted                                 $0.17       $0.57       $(1.57)

                                           Fiscal Year Fiscal Year Fiscal Year
                                               2002        2001       2000
    Net income (loss) as reported           $(68,968)   $100,750    $69,937
    Impact of accounting correction           (1,145)     (2,009)      (761)
    Net income (loss) as restated           $(70,113)    $98,741    $69,176

    Earnings per share (previously
     reported):
      Basic                                   $(2.40)      $3.64      $2.77
      Diluted                                 $(2.40)      $3.50      $2.56

    Accounting correction:
      Basic                                   $(0.04)     $(0.07)    $(0.03)
      Diluted                                 $(0.04)     $(0.07)    $(0.03)

    Earnings per share (as restated):
      Basic                                   $(2.44)      $3.57      $2.74
      Diluted                                 $(2.44)      $3.43      $2.53


    Summarized statement of operations financial information is as follows
               (unaudited, in thousands except per share data):

                            Three Months Ended            Six Months Ended
                                 Jan. 1,      Apr. 3,               Apr. 3,
                    April 2,       2005       2004 (A)    April 2,  2004 (A)
                      2005      (restated)  (restated)      2005  (restated)

    Net sales       $131,175    $126,022     $125,808    $257,197  $233,759
    Cost of
     sales (B)        72,688      74,444       74,260     147,132    140,860
    Gross profit      58,487      51,578       51,548     110,065     92,899
    Operating
     expenses:
      Research &
       development
       (B)            14,175      14,276       15,587      28,451    30,674
      Selling,
       general &
       administrative
       (B)            28,765      28,438       29,532      57,203    57,063
      Restructuring,
       impairment and
       other charges    (40)         300           --         260        237
      Intangibles
       amortization    1,528       1,493        1,770       3,021      3,699
        Total
         operating
         expenses     44,428      44,507       46,889      88,935     91,673
    Income from
     operations       14,059       7,071        4,659      21,130      1,226
    Other income,
     net (B)             790         907          408       1,697      2,673
    Income from
     continuing
     operations
     before income
     taxes and
     minority
     interest         14,849       7,978        5,067      22,827      3,899
    Provision
     (benefit) for
     income taxes
     (C)             (4,728)       2,770        2,418     (1,958)      1,359
    Income from
     continuing
     operations
     before minority
     interest         19,577       5,208        2,649      24,785      2,540
    Minority
     interest (B) (D)     --         180          145         180        478
    Income from
     continuing
     operations       19,577       5,388        2,794      24,965      3,018
    Income from
     discontinued
     operations           --          --          218          --        218
    Net income       $19,577      $5,388       $3,012     $24,965    $ 3,236

    Net income per
     diluted share:
      Income from
       continuing
       operations      $0.63       $0.17        $0.09       $0.81      $0.10
      Income from
       discontinued
       operations,
       net of income
       taxes              --          --         0.01          --      0.01
      Net income       $0.63       $0.17        $0.10       $0.81      $0.11

    Shares used in
     computation:
      Diluted         31,112      30,867       30,551      30,991     30,442


    All periods except for the three and six months ended April 2, 2005 have
been restated to reflect the correct accounting for the Company's deferred
compensation plans.

    (A)  The three months and six months ended April 3, 2004 represent a 14-
week and 27-week period, respectively.
    (B)  The quarter ended April 2, 2005, includes a $323 ($0.01 per diluted
share) reduction in charges to research and development associated with our
previously communicated decision to discontinue future product development and
investments in the semiconductor lithography market within our Lambda Physik
subsidiary.  The quarter ended January 1, 2005 includes a charge of $3,061
(net of minority interest of $137 ($0.10 per diluted share)) associated with
our decision to discontinue future product development and investments in the
semiconductor lithography market within our Lambda Physik subsidiary.  As a
result, cost of sales includes $2,257; research & development includes $267;
selling, general and administrative includes $137 and other income (expense),
net includes $214 for the six months ended April 2, 2005.
    (C)  The quarter ended April 2, 2005, includes a tax benefit for the
reversal of a deferred tax valuation allowance permissible under Statement of
Financial Accounting Standards (SFAS) No. 109 "Accounting for Income Taxes" of
$9,571 ($0.31 per diluted share) related to our Lambda Physik segment.  The
quarter ended January 1, 2005 includes a tax benefit of  $479 ($0.02 per
diluted share) related to federal tax law changes enacted in the first quarter
of fiscal 2005.
    (D)  The elimination of minority interest during the quarter ended April
2, 2005 was due to the acquisition of the remaining outstanding shares of
Lambda Physik.


Summarized balance sheet information is as follows (unaudited, in thousands):

                                                     Apr. 2,        Oct. 2,
                                                      2005          2004 (A)
                                                                  (restated)
                                      ASSETS
    Current assets:
      Cash, cash equivalents and
       short-term investments                       $212,495       $170,734
      Restricted cash, cash equivalents
       and short-term investments (B)                 15,411         15,343
      Accounts receivable, net                        90,301         96,825
      Inventories                                    108,907        104,698
      Prepaid expenses and other assets               55,954         62,572
        Total current assets                         483,068        450,172
    Property and equipment, net                      162,455        166,054
    Restricted cash, cash equivalents and
     short-term investments (B)                       16,545         23,580
    Other assets                                     135,974        117,520
        Total assets                                $798,042       $757,326

                       LIABILITIES AND STOCKHOLDERS' EQUITY
    Current liabilities:
      Current portion of long-term obligations       $13,360        $13,700
      Accounts payable                                17,226         17,648
      Other current liabilities                       74,586         73,181
        Total current liabilities                    105,172        104,529
    Long-term obligations                             13,961         14,215
    Other long-term liabilities                       52,613         54,530
    Total stockholders' equity                       626,296        584,052
        Total liabilities and
         stockholders' equity                       $798,042       $757,326

    (A)  Derived from audited financial statements for the year ended October
2, 2004, and restated to reflect the correct accounting for the Company's
deferred compensation plans.
    (B)  Represents cash, cash equivalents and short-term investments at
April 2, 2005 restricted under the Star notes payable arrangement ($30,360),
for close out costs associated with the purchase of the remaining outstanding
shares of Lambda Physik AG ($1,367) and other ($229).

    Reconciliation of GAAP to Non-GAAP summarized statement of operations
(unaudited, in thousands except per share data, after-tax and net of minority
                           interest, as restated):

                              Three Months Ended           Six Months Ended
                        April 2,     Jan. 1,   April 3     April 2,  April 3
                          2005        2005       2004       2005       2004
    GAAP net income     $19,577      $5,388     $3,012     $24,965    $3,236
    SFAS 109 favorable
     impact due to
     final step
     acquisition and
     the merger of
     two internal
     entities           (9,571)          --         --     (9,571)        --
    Charges associated
     with discontinuing
     future product
     development and
     investments in the
     semiconductor
     lithography market   (323)       3,061         --       2,738        --
    Tax benefit related
     to federal tax
     law changes             --       (479)         --       (479)        --
    Non-GAAP net
     income              $9,683     $ 7,970    $ 3,012     $17,653   $ 3,236

    Non-GAAP net
     income per diluted
     share                $0.31       $0.26      $0.10       $0.57     $0.11


    The Company's conference call scheduled for 1:30 p.m. PDT today will
include discussions relative to the current quarter results and some comments
regarding forward looking guidance on future operating performance.

    The statements in this press release that relate to future plans, events
or performance, including statements such as with respect to future demand,
positive signs for products used in flat panel display manufacturing,
electronics packaging and materials processing, and Lambda's march towards
operational and financial excellence are forward-looking statements.  Factors
that could cause actual results to differ materially include risks and
uncertainties, including risks associated to currency adjustments, contract
cancellations, manufacturing risks, competitive factors, and uncertainties
pertaining to customer orders, demand for products and services, and
development of markets for the Company's products and services and other risks
identified in the Company's SEC filings.  Actual results, events and
performance may differ materially.  Readers are cautioned not to place undue
reliance on these forward-looking statements, which speak only as of the date
hereof.  The Company undertakes no obligation to update these forward-looking
statements as a result of events or circumstances after the date hereof or to
reflect the occurrence of unanticipated events.
    The Company may provide non-GAAP financial measures (as defined by the SEC
in Regulation G) in our earnings conference call and in any other Company
presentations during the quarter.  Non-GAAP financial measures are intended to
supplement the user's overall understanding of the Company's current financial
performance and its future prospects. Any non-GAAP financial measures are not
intended to replace the Company's GAAP results.  The Company's intention is to
include the most directly comparable GAAP financial measures and a
reconciliation of the differences between each non-GAAP financial measure used
and the most directly comparable GAAP financial measure.
    Readers are encouraged to refer to the risk disclosures described in the
Company's reports on Forms 10-K, 10-Q and 8K, as applicable.

    Founded in 1966, Coherent, Inc. is a Standard & Poor's SmallCap 600
company and a world leader in providing photonics based solutions to the
commercial and scientific research markets. Please direct any questions to
Leen Simonet, Chief Financial Officer at 408-764-4161. For more information
about Coherent, visit the Company's Web site at http://www.coherent.com/ for
product and financial updates.


SOURCE Coherent, Inc.




Back to Topback to top

Related links:
  • http://www.coherent.com
    CONTACT:
    Leen Simonet, +1-408-764-4161, for Coherent,
    Inc.